News wire
Drugs and medical devices
Pharmaceuticals, implants and medical devices: safety communications, label changes, approvals and the litigation that follows them.
Source check 5 min ago · Newest item 7 hr ago · 1,441 stories this week · 87 of 90 publishers answering · Browse publishers · RSS feed
Filter stories (1)
Saved on this browser
Drugs and medical devices
Monday, November 9
Pharmacy Tech's COVID Vax Bias Suit Falls Short At 7th Circ.
MedWatch Alert: FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition: FDA Safety Communication
FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition: FDA Safety Communication
Convenience Kit Correction: Cardinal Health Updates Use Instructions for Presource Packs Containing BD Alaris Pump Infusion Sets
Cardinal Health Presource Kits may contain BD Alaris Pump Infusion Sets with Updated Use Instructions.
Friday, November 6
'Halfhearted' Conferral Not Enough In Mosquito-Patch Feud
2 Del. Rulings Show Postclosing Earnout Arrangement Risks
Medtronic Hit With Antitrust Suit Over Surgical Stapler
MedWatch Alert: FDA Investigating Serious Risk of Malignancy Linked to Zolgensma Gene Therapy
FDA Investigating Serious Risk of Malignancy Linked to Zolgensma Gene Therapy: FDA Safety Communication
Medical Devices; Ear, Nose, and Throat Devices; Classification of the External Mechanical Stimulator for the Relief of Congestion
The Food and Drug Administration (FDA) is classifying the external mechanical stimulator for the relief of congestion into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the external mechanical stimulator for the relief of congestion. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access to…
Thursday, November 5
5 Firms Guide Brains Bioceutical's $750M SPAC Merger
Ex-Sales Leader Violated 'Secrecy' Pact, J&J Ortho Unit Says
STAT+: A possible comeback for a failed sickle cell gene therapy
How Analytical Advances Reshape Biologic Patent Strategy
BREAKING: Albertsons, Safeway Owe Wash. $900M Over Opioid Diversion
Ropes & Gray-Led Pharma Biz Offers $541M For Swedish Rival
FDA’s Draft Guidance on Demonstrating Substantial Evidence of Effectiveness
Medical Devices; Hematology and Pathology Devices; Classification of the Digital Cervical Cytology Slide Imaging System With Artificial Intelligence Algorithm
The Food and Drug Administration (FDA) is classifying the digital cervical cytology slide imaging system with artificial intelligence algorithm into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the digital cervical cytology slide imaging system with artificial intelligence algorithm. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We…
Medical Devices; Orthopedic Devices; Classification of the Wearable Vibration Device for Orthopedic Use
The Food and Drug Administration (FDA) is classifying the wearable vibration device for orthopedic use into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the wearable vibration device for orthopedic use. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative…
Medical Devices; Neurological Devices; Classification of the Prognostic Assessment Software of Mild Cognitive Impairment
The Food and Drug Administration (FDA) is classifying the prognostic assessment software of mild cognitive impairment into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the prognostic assessment software of mild cognitive impairment. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access to…
Wednesday, November 4
Pharmacy Worker Says Dosage Machine Cut Off Fingertip
Anti-Pot Group Eyes New Repeal Pushes After Mass. Loss
Philips settles with DOJ over recalled CPAP machines
STAT+: Former Madrigal Pharmaceuticals executive alleges coverup of safety issues tied to its drug
Tuesday, November 3
Va., Mo. Voters Deliver Wins For Abortion Rights
Feds Dropping Charges Against Harvard Researcher
Birth Control Clip Maker Must Face Injury Case Trial
PBM Says Fla. Collusion Suit Belongs In Federal Court
Fed. Circ. Unsure How Judge Messed Up Drug Patent Ruling
Squires Grants 4 IPRs, Denies 6 Before Handing Over Power
Choice Spine Says Polsinelli Sanctions Bid Is Premature
Connect the news to your market.
Research the firms, offices and conference relationships behind the headlines.